Nutex Health Stock Performance
| NUTX Stock | USD 51.75 4.15 7.42% |
Nutex Health holds a performance score of 14 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 3.42, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Nutex Health will likely underperform. Use Nutex Health skewness, day typical price, and the relationship between the downside variance and daily balance of power , to analyze future returns on Nutex Health.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Nutex Health are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Nutex Health showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (7.42) | Five Day Return 12.5 | Year To Date Return 49.05 | Ten Year Return (99.14) | All Time Return (99.14) |
Last Split Factor 1:10 | Dividend Date 2019-11-01 | Last Split Date 2024-07-03 |
1 | Nutex Health Inc. Sees Large Growth in Short Interest - MarketBeat | 12/31/2024 |
2 | Acquisition by Vo Thomas T. of 5000 shares of Nutex Health subject to Rule 16b-3 | 01/08/2025 |
3 | Nutex Health Hospitals Earn Multiple Community Honors and Awards in Q4 | 01/21/2025 |
4 | Acquisition by Vo Thomas T. of 114884 shares of Nutex Health at 0.48 subject to Rule 16b-3 | 01/24/2025 |
5 | Baader Bank Aktiengesellschaft Invests 206,000 in Nutex Health Inc. - MarketBeat | 02/04/2025 |
6 | Nutex Health stock soars to 52-week high of 60.18 amid robust growth - Investing.com India | 02/13/2025 |
7 | Disposition of 20000 shares by Jon Bates of Nutex Health subject to Rule 16b-3 | 02/14/2025 |
8 | Legato Capital Management LLC Has 1 Million Holdings in Nutex Health Inc. - MarketBeat | 02/18/2025 |
9 | Disposition of 125498 shares by Premier Macy Management Holdings, Llc of Nutex Health at 2.2054 subject to Rule 16b-3 | 02/26/2025 |
10 | NUTEX HEALTH SCHEDULES 2024 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS RELEASE AND CONFERENCE CALL | 03/17/2025 |
| Begin Period Cash Flow | 34.3 M |
Nutex |
Nutex Health Relative Risk vs. Return Landscape
If you would invest 2,938 in Nutex Health on December 20, 2024 and sell it today you would earn a total of 2,237 from holding Nutex Health or generate 76.14% return on investment over 90 days. Nutex Health is currently generating 1.1551% in daily expected returns and assumes 6.2979% risk (volatility on return distribution) over the 90 days horizon. In different words, 56% of stocks are less volatile than Nutex, and 77% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Nutex Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nutex Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Nutex Health, and traders can use it to determine the average amount a Nutex Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1834
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | NUTX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.3 actual daily | 56 56% of assets are less volatile |
Expected Return
| 1.16 actual daily | 23 77% of assets have higher returns |
Risk-Adjusted Return
| 0.18 actual daily | 14 86% of assets perform better |
Based on monthly moving average Nutex Health is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nutex Health by adding it to a well-diversified portfolio.
Nutex Health Fundamentals Growth
Nutex Stock prices reflect investors' perceptions of the future prospects and financial health of Nutex Health, and Nutex Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nutex Stock performance.
| Return On Equity | -0.35 | ||||
| Return On Asset | 0.0376 | ||||
| Profit Margin | (0.14) % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 560.26 M | ||||
| Shares Outstanding | 5.44 M | ||||
| Price To Earning | 3.90 X | ||||
| Price To Book | 4.95 X | ||||
| Price To Sales | 1.04 X | ||||
| Revenue | 247.65 M | ||||
| Gross Profit | 86.22 M | ||||
| EBITDA | (14.58 M) | ||||
| Net Income | (45.79 M) | ||||
| Cash And Equivalents | 47.6 M | ||||
| Cash Per Share | 0.07 X | ||||
| Total Debt | 275.76 M | ||||
| Debt To Equity | 0.44 % | ||||
| Current Ratio | 4.43 X | ||||
| Book Value Per Share | 11.59 X | ||||
| Cash Flow From Operations | 1.26 M | ||||
| Earnings Per Share | (9.18) X | ||||
| Market Capitalization | 303.93 M | ||||
| Total Asset | 398.25 M | ||||
| Retained Earnings | (409.07 M) | ||||
| Working Capital | 32.54 M | ||||
About Nutex Health Performance
Evaluating Nutex Health's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Nutex Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Nutex Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 6.69 | 6.35 | |
| Return On Tangible Assets | (0.11) | (0.12) | |
| Return On Capital Employed | (0.08) | (0.08) | |
| Return On Assets | (0.10) | (0.11) | |
| Return On Equity | (0.86) | (0.81) |
Things to note about Nutex Health performance evaluation
Checking the ongoing alerts about Nutex Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Nutex Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Nutex Health is way too risky over 90 days horizon | |
| Nutex Health appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 247.65 M. Net Loss for the year was (45.79 M) with profit before overhead, payroll, taxes, and interest of 86.22 M. | |
| Nutex Health has a poor financial position based on the latest SEC disclosures | |
| About 39.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from finance.yahoo.com: NUTEX HEALTH SCHEDULES 2024 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS RELEASE AND CONFERENCE CALL |
- Analyzing Nutex Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nutex Health's stock is overvalued or undervalued compared to its peers.
- Examining Nutex Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Nutex Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nutex Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Nutex Health's stock. These opinions can provide insight into Nutex Health's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Nutex Stock Analysis
When running Nutex Health's price analysis, check to measure Nutex Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutex Health is operating at the current time. Most of Nutex Health's value examination focuses on studying past and present price action to predict the probability of Nutex Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutex Health's price. Additionally, you may evaluate how the addition of Nutex Health to your portfolios can decrease your overall portfolio volatility.